Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)-Reference-Cited by-同舟云学术

Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)

Published:2021-12 Issue:12 Volume:174 Page:W116-W117
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Qaseem Amir¹^ORCID,Yost Jennifer²^ORCID,Etxeandia-Ikobaltzeta Itziar¹^ORCID,Abraham George M.³^ORCID,Jokela Janet A.⁴^ORCID,Miller Matthew C.⁵^ORCID,Forciea Mary Ann⁶^ORCID,Humphrey Linda L.⁷,

Affiliation:

1. American College of Physicians, Philadelphia, Pennsylvania

2. Villanova University, Villanova, Pennsylvania

3. Saint Vincent Hospital-Worcester Medical Center, Worcester, Massachusetts

4. University of Illinois College of Medicine at Urbana-Champaign, Champaign, Illinois

5. Penn Medicine Radnor, Radnor, Pennsylvania

6. Penn Medicine, Philadelphia, Pennsylvania

7. Portland Veterans Affairs Medical Center and Oregon Health & Science University, Portland, Oregon

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality appraisal of clinical practice guidelines addressing massage interventions using the AGREE II instrument;Systematic Reviews;2024-03-08

2. Population Pharmacokinetics of Remdesivir and GS-441524 in Hospitalized COVID-19 Patients;Antimicrobial Agents and Chemotherapy;2022-06-21

3. Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2, Update Alert 3);Annals of Internal Medicine;2022-05

4. The synergistic effects of testosterone and phophodiesterase-5 inhibitor combination on oxidative stress markers, matrix metalloproteinases and oxidative DNA damage: A randomized controlled experimental study;Revista Internacional de Andrología;2022-04

5. Developing trustworthy recommendations as part of an urgent response (1–2 weeks): a GRADE concept paper;Journal of Clinical Epidemiology;2021-01